Related Experiment Videos
Macrophage-mediated modulation of hepatocyte protein synthesis. Effect of dexamethasone
Abstract:
We have previously reported an in vitro model demonstrating decreased hepatocyte protein synthesis following co-culture with macrophage-rich peritoneal cells (MRPC) in Sprague-Dawley rats. These observations have been proposed by us and others to represent a possible model for macrophage- or Kupffer cell-mediated modulation of hepatocyte function. Such a mechanism may play a role in the etiology of hepatic failure in sepsis. This effect is shown in this investigation to be completely blocked by dexamethasone at concentrations equal to or greater than 10(-9) M. The presence of lymphocyte-activating factor in the MRPC-conditioned medium is suppressed at the same concentration of dexamethasone. Resident MRPC were shown to secrete significant amounts of lymphocyte-activating factor activity without further in vitro activation. These results support the concept that the MRPC mediation of decreased hepatocyte protein synthesis is inflammatory in nature and possibly associated with macrophage activation.
Insights
Dexamethasone blocks macrophage-induced reduction in liver cell protein synthesis, suggesting an inflammatory mechanism in liver failure during sepsis. This finding highlights potential therapeutic targets for hepatic dysfunction.
Area of Science:
- Hepatology
- Immunology
- Sepsis Research
Background:
- Macrophage-rich peritoneal cells (MRPC) co-culture in vitro models show decreased hepatocyte protein synthesis.
- This MRPC-mediated effect is proposed as a model for macrophage/Kupffer cell modulation of hepatocyte function.
- Such mechanisms may contribute to hepatic failure in sepsis.
Purpose of the Study:
- To investigate the role of dexamethasone in modulating MRPC-induced suppression of hepatocyte function.
- To determine if dexamethasone affects lymphocyte-activating factor (LAF) production by MRPC.
- To explore the inflammatory nature of MRPC-mediated effects on hepatocytes.
Main Methods:
- In vitro co-culture model using Sprague-Dawley rat hepatocytes and MRPC.
- Treatment with varying concentrations of dexamethasone.
- Measurement of hepatocyte protein synthesis.
- Assay for lymphocyte-activating factor activity in MRPC-conditioned medium.
Main Results:
- Dexamethasone completely blocked the decrease in hepatocyte protein synthesis at concentrations ≥ 10(-9) M.
- The same dexamethasone concentrations suppressed lymphocyte-activating factor (LAF) presence in MRPC-conditioned medium.
- Resident MRPC spontaneously secreted significant LAF activity without further in vitro activation.
Conclusions:
- Dexamethasone effectively inhibits MRPC-mediated suppression of hepatocyte protein synthesis.
- The anti-inflammatory action of dexamethasone is linked to reduced LAF activity.
- Results support an inflammatory basis for MRPC-induced hepatocyte dysfunction, potentially involving macrophage activation.